GSK shares moving higher after smashing Q3 earnings and increasing guidance
- Better than expected Q3 sales and profit growth- Increased guidance across all business units- RSV vaccine granted priority FDA reviewBiopharma company GSK (GSK) delivered better than expected third quarter sales and profit...
02 November 2022